CHICAGO — Nearly three-quarters of older adults with advanced cancer value quality of life over extending survival, according to study results presented at ASCO Annual Meeting.However, data showed that regardless of patient preference for quality of life or survival, clinical outcomes appeared to be similar.| www.healio.com
CHICAGO — Dexrazoxane helped adolescents and young adults with cancer who received doxorubicin chemotherapy have significantly better heart function and structure years after diagnosis, according to findings presented at ASCO Annual Meeting.The results showed cardioprotective effects of dexrazoxane could be seen more than 10 years after therapy and increased with doxorubicin dose.| www.healio.com
The FDA has cleared NeuroSigma’s second-generation Monarch eTNS System for treatment of pediatric ADHD, the company announced in a press release.The Monarch 2.0 device is approximately one-third the size of the first-generation Monarch eTNS System and includes a high-resolution color LCD screen and optimized user interface. It is indicated as a monotherapy for patients aged 7 to 12 years| www.healio.com
In this episode, host Hansa Bhargava, MD, discusses computer science and technology in medicine and the inequities and lack of preventive care in pediatrics with Sharief Taraman, MD.| www.healio.com
Medical mistrust continues to be a major issue in the care of patients with multiple myeloma — particularly among Black individuals according to findings published in Cancer Medicine.Strong patient-oncologist relationships and effective communication are essential to address and mitigate this, researchers concluded.| www.healio.com